Autobio Diagnostics Co Ltd
SSE:603658
Autobio Diagnostics Co Ltd
Operating Income
Autobio Diagnostics Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Autobio Diagnostics Co Ltd
SSE:603658
|
Operating Income
¥1.3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Operating Income
¥2.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Operating Income
¥814.7m
|
CAGR 3-Years
9%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
Winner Medical Co Ltd
SZSE:300888
|
Operating Income
¥749.4m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Operating Income
¥1.8B
|
CAGR 3-Years
20%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Autek China Inc
SZSE:300595
|
Operating Income
¥754.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
See Also
What is Autobio Diagnostics Co Ltd's Operating Income?
Operating Income
1.3B
CNY
Based on the financial report for Mar 31, 2024, Autobio Diagnostics Co Ltd's Operating Income amounts to 1.3B CNY.
What is Autobio Diagnostics Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
15%
Over the last year, the Operating Income growth was 17%. The average annual Operating Income growth rates for Autobio Diagnostics Co Ltd have been 15% over the past three years , 15% over the past five years .